IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

HIV

The treatment of HIV (human immunodeficiency virus) aims to suppress the virus, prevent the progression of the disease to AIDS (acquired immunodeficiency syndrome), and improve the patient’s quality of life. Treatment options may include , Antiretroviral therapy (ART), Pre-exposure prophylaxis (PrEP), Post-exposure prophylaxis (PEP), Treatment of opportunistic infections, Vaccinations, Supportive care.

Indian Pharma Network

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

bictegravir, emtricitabine, and tenofovir alafenamide tablets

bictegravir, emtricitabine, and tenofovir alafenamide tablets, for oral use Initial U.S. Approval: 2018

Facts about bictegravir, emtricitabine, and tenofovir alafenamide tablets

Approval Date: 2018
Proprietary Name: On Request
Active Ingredient(s): bictegravir, emtricitabine, and tenofovir alafenamide tablets
Dosage Forms And Strengths: Tablets: 50 mg of bictegravir (equivalent to 52.5 mg of bictegravir sodium), 200 mg of emtricitabine, and 25 mg of tenofovir alafenamide (equivalent to 28 mg of tenofovir alafenamide fumarate)
Company: Gilead Sciences
Used for: HIV
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “bictegravir, emtricitabine, and tenofovir alafenamide tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

LETERMOVIR Tablets

letermovir injection, for intravenous use Initial U.S. Approval: 2017

Medicine Name: Prevymis
Generic Name: Letermovir
Dosage Form & Strength: Tablet: 240 mg; 480 mg and Injection: 240 mg/12 mL (20 mg/mL) or 480 mg/24 mL (20 mg/mL) in a single-dose vial
Manufactured By: Merck

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import LETERMOVIR Tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

SUNLENCA (lenacapavir) injection

SUNLENCA (lenacapavir) injection, for subcutaneous use
Initial U.S. Approval: 2022

Sunlenca is a prescription medicine that is used with other human immunodeficiency virus-1 (HIV-1) medicines to treat HIV-1 infection in adults. HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS). Sunlenca belongs to a new class of drugs called capsid inhibitors.

Brand Name: SUNLENCA
Generic Name: lenacapavir
Strength: Tablets: 300 mg
Injection: 463.5 mg/1.5 mL (309 mg/mL) in single-dose vials.
Manufacturer: Gilead Sciences, Inc.
Approved By: EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “SUNLENCA (lenacapavir) injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for SUNLENCA (lenacapavir) injection price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398